At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
NAGE Niagen Bioscience
Pre-Mkt 08-24 07:44:49 EDT
3.21
+0.06
+1.90%
盘前3.21
+0.000.00%
06:50 EDT
High3.24Low3.14Vol370.32K
Open3.17D1 Closing3.15Amplitude3.02%
Mkt Cap255.66MTradable Cap179.18MTotal Shares79.64M
T/O1.19MT/O Rate0.66%Tradable Shares55.82M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Niagen Bioscience Expands Tru Niagen Retail Distribution Through GNC, Sam’s Club Partnership
Reuters  ·  08-20
Niagen Bioscience Expands Tru Niagen Retail Distribution Through GNC, Sam’s Club Partnership
NAGE Shines Spotlight on New NAD+ Skin‑Aging Trial as Cosmetic Demand Heats Up
TIPRANKS  ·  08-20
NAGE Shines Spotlight on New NAD+ Skin‑Aging Trial as Cosmetic Demand Heats Up
Niagen Bioscience to Present at Midwest IDEAS Investor Conference
Reuters  ·  08-12
Niagen Bioscience to Present at Midwest IDEAS Investor Conference
Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof
Simply Wall St.  ·  08-07
Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof
Niagen Bioscience CFO highlights telehealth as ‘high-expectation growth channel’
TIPRANKS  ·  08-07
Niagen Bioscience CFO highlights telehealth as ‘high-expectation growth channel’
Meet Niagen Bioscience: Fly exclusive interview with CFO Ozan Pamir
TIPRANKS  ·  08-07
Meet Niagen Bioscience: Fly exclusive interview with CFO Ozan Pamir
Bananas, Bread, Bones…Walmart Seals Healthy Aging Deal With Niagen Bioscience
TIPRANKS  ·  08-06
Bananas, Bread, Bones…Walmart Seals Healthy Aging Deal With Niagen Bioscience
Niagen Bioscience announces Tru Niagen is now available at Walmart
TIPRANKS  ·  08-06
Niagen Bioscience announces Tru Niagen is now available at Walmart
Niagen Bioscience price target lowered to $10 from $12 at Roth Capital
TIPRANKS  ·  08-05
Niagen Bioscience price target lowered to $10 from $12 at Roth Capital
Niagen Bioscience Posts Investor Presentation Focused on NAD+ Science and Healthy-Aging Products
Reuters  ·  08-05
Niagen Bioscience Posts Investor Presentation Focused on NAD+ Science and Healthy-Aging Products
Niagen Bioscience Inc Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-05
Niagen Bioscience Inc Reports Results for the Quarter Ended June 30 - Earnings Summary
Niagen Bioscience Q2 Net Sales Fall, Missing Estimates
Reuters  ·  08-05
Niagen Bioscience Q2 Net Sales Fall, Missing Estimates
Niagen Bioscience Q2 EPS $0.01 Misses $0.02 Estimate, Sales $29.785M Miss $30.690M Estimate
Benzinga Earnings  ·  08-05
Niagen Bioscience Q2 EPS $0.01 Misses $0.02 Estimate, Sales $29.785M Miss $30.690M Estimate
Niagen Bioscience: Ingredient Business Expected to be Lower than Prior Year as Some Commercial Partners Continue to Face More Competitive Market
THOMSON REUTERS  ·  08-05
Niagen Bioscience: Ingredient Business Expected to be Lower than Prior Year as Some Commercial Partners Continue to Face More Competitive Market
Niagen Bioscience: Expect Niagen Plus Growth & New Skincare Partnerships to Become Meaningful Contributors Beginning 2027
THOMSON REUTERS  ·  08-05
Niagen Bioscience: Expect Niagen Plus Growth & New Skincare Partnerships to Become Meaningful Contributors Beginning 2027
Niagen Bioscience Inc Q2 Net Income USD 963 Thousand
THOMSON REUTERS  ·  08-05
Niagen Bioscience Inc Q2 Net Income USD 963 Thousand
Niagen Bioscience Inc Q2 EPS USD 0.01 VS. Ibes Estimate USD 0.01
THOMSON REUTERS  ·  08-05
Niagen Bioscience Inc Q2 EPS USD 0.01 VS. Ibes Estimate USD 0.01
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
THOMSON REUTERS  ·  08-05
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
Niagen Bioscience Taps Evotec to Advance Preclinical Development of Nb4168 Rare-Disease Candidate
Reuters  ·  08-03
Niagen Bioscience Taps Evotec to Advance Preclinical Development of Nb4168 Rare-Disease Candidate
Niagen Bioscience - Plans Ind Application to FDA for Nb4168
THOMSON REUTERS  ·  08-03
Niagen Bioscience - Plans Ind Application to FDA for Nb4168

Introduction

Company Name.
Niagen Bioscience
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--